Piracetam is a drug that is sold as a myoclonus therapy and a cognitive enhancer. The evidence for its use is mixed, with some research suggesting small benefits in particular populations and others showing no benefit at all. Many European countries sell piracetam as a drug. Despite the FDA’s ban, piracetam is marketed as a dietary supplement in the United States.
2-oxo-1-pyrrolidine acetamide is the chemical name for piracetam, which belongs to the racetams group. It has the same 2-oxo-pyrrolidone base structure as pyroglutamic acid and is a derivative of the neurotransmitter GABA. Piracetam is a cyclic GABA derivative (gamma-Aminobutyric acid). The anticonvulsants levetiracetam and brivaracetam, as well as the putative nootropics aniracetam and phenylpiracetam, are all related.